All articles by RanjithKumar Dharma
RanjithKumar Dharma
FDA approves Abbott’s Epic Max stented tissue valve
Epic Max features a low-profile frame that enables potential future transcatheter interventions for patients.
FDA grants 510(k) clearance to CoreLink’s Siber Ti System
The Siber Ti System provides a comprehensive portfolio of fully porous, nano surfaced, 3D-printed implants.
Acutis Diagnostics selects Sophia Genetics’ technology for genomic assay
The new test is expected to help with genomic screening during patient recruitment for oncology clinical studies.
Health Canada authorises bioLytical’s syphilis antibody test
The test can identify both HIV-1/2 and syphilis antibodies from one simple fingerprick sample.
Illumina and GenoScreen introduce new tuberculosis test
The test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.
Askel to commercialise COPLA implant in US and EU by 2028
Designed to treat knee cartilage defects, the implant is being used for selected patients in a clinical trial.
Medtronic announces integration of NVIDIA’s AI tech with GI Genius platform
The GI Genius module is intended to help physicians identify polyps that can cause colorectal cancer.
Wesper receives FDA approval for next-generation sleep care device
The new device will gather significant clinical-grade longitudinal data to diagnose and monitor treatment efficacy over time.
Synchron to start patient enrolment in brain-computer interface study
The trial will evaluate the impact of the Synchron Switch on daily tasks, including texting, emailing and online shopping.
US FDA issues 510(k) approval to SurgVision’s Explorer Air II device
The Explorer Air II device will meet the requirements of oncological intraoperative fluorescence imaging.